Question 1

How do benzodiazepines enhance GABA's inhibitory effects in the brain?

Accepted Answer

Benzodiazepines like clorazepate act on GABAA receptors, increasing the frequency of chloride channel opening and enhancing GABA's affinity for these receptors. They also inhibit GABA reuptake, prolonging GABA's presence in the synaptic cleft. This combination raises the seizure threshold and amplifies inhibitory effects on neuronal excitability.

Question 2

What is the mechanism of action of tiagabine in epilepsy treatment?

Accepted Answer

Tiagabine inhibits the GABA transporter GAT-1, preventing GABA reuptake from the synaptic cleft. By prolonging GABA's presence at the synapse, tiagabine intensifies inhibitory signaling and prevents abnormal electrical activity that leads to seizures. This mechanism is particularly effective for managing focal seizure types in epilepsy patients.

Question 3

How does sodium valproate differ from benzodiazepines and tiagabine?

Accepted Answer

Unlike benzodiazepines and tiagabine, sodium valproate does not directly interact with GABA receptors or transporters. Instead, it modulates GABA metabolism by increasing GABA concentration in the brain. This elevation in GABA levels significantly reduces seizure activity through an indirect mechanism distinct from receptor or transporter targeting.

Question 4

Which types of seizures are effectively treated by GABA pathway potentiators?

Accepted Answer

GABA pathway potentiators treat various epilepsy forms. Benzodiazepines and sodium valproate effectively manage absence seizures, while tiagabine is particularly useful for focal seizures. These drugs work by enhancing inhibitory neurotransmission to prevent abnormal electrical activity and raise seizure thresholds across different seizure types.

Question 5

How are GABA pathway potentiators absorbed, metabolized, and eliminated?

Accepted Answer

When administered orally, GABA pathway potentiators are well absorbed by the body. They are metabolized primarily in the liver through hepatic processes and subsequently excreted in the urine. This hepatic metabolism and renal excretion pathway is consistent across benzodiazepines, tiagabine, and sodium valproate formulations.

Question 6

What are the common side effects associated with GABA pathway potentiators?

Accepted Answer

Common side effects of GABA pathway potentiators include drowsiness, dizziness, gastrointestinal disturbances, ataxia, and tremors. These adverse effects reflect the drugs' enhancement of central inhibitory neurotransmission and may vary in severity depending on dosage, individual patient factors, and duration of treatment.

Question 7

How do GABA pathway potentiators compare to other antiepileptic drug classes?

Accepted Answer

GABA pathway potentiators enhance inhibitory neurotransmission, contrasting with other antiepileptic drugs like sodium channel blockers or calcium channel blockers that work through different mechanisms. Understanding these distinct approaches helps clinicians select appropriate medications based on seizure type and patient-specific factors for optimal epilepsy management.

Anti-epileptica: GABA-erge padpotentiator

Browse More Videos